{"id":511740,"date":"2021-07-12T08:18:09","date_gmt":"2021-07-12T12:18:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/"},"modified":"2021-07-12T08:18:09","modified_gmt":"2021-07-12T12:18:09","slug":"nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/","title":{"rendered":"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021"},"content":{"rendered":"
\n

\n Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) — <\/strong>Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that Chief Executive Officer Faz Chowdhury, Ph.D. will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 \u2013 15, 2021.<\/p>\n

Dr. Chowdhury will deliver his corporate presentation on July 13 at 1:00pm ET.<\/p>\n

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com<\/u><\/a>.<\/p>\n

Investors can register\u00a0here.<\/u><\/a><\/p>\n

\n About Nemaura Medical, Inc.<\/strong>\n <\/p>\n

Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT\u00ae<\/sup> and proBEAT\u2122<\/sup>. sugarBEAT\u00ae<\/sup>, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT\u00ae<\/sup> to the U.S. FDA. proBEAT\u2122<\/sup> combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the U.S. as a general wellness product as part of its BEAT\u00ae<\/sup>diabetes program.<\/p>\n

The Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023.<\/p>\n

For more information, please visit www.NemauraMedical.com<\/a>.<\/p>\n

\n Contact:<\/strong>
\n
Jules Abraham
CORE IR
917-885-7378
julesa@coreir.com<\/u><\/a><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that Chief Executive Officer Faz Chowdhury, Ph.D. will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 \u2013 15, 2021. Dr. Chowdhury will deliver his corporate presentation on July 13 at 1:00pm ET. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. Investors can register\u00a0here. About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT\u00ae and proBEAT\u2122. … <\/p>\n

Continue reading “Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511740","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that Chief Executive Officer Faz Chowdhury, Ph.D. will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 \u2013 15, 2021. Dr. Chowdhury will deliver his corporate presentation on July 13 at 1:00pm ET. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. Investors can register\u00a0here. About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT\u00ae and proBEAT\u2122. … Continue reading "Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T12:18:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021\",\"datePublished\":\"2021-07-12T12:18:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/\",\"name\":\"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==\",\"datePublished\":\"2021-07-12T12:18:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/","og_locale":"en_US","og_type":"article","og_title":"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021 - Market Newsdesk","og_description":"Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that Chief Executive Officer Faz Chowdhury, Ph.D. will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 \u2013 15, 2021. Dr. Chowdhury will deliver his corporate presentation on July 13 at 1:00pm ET. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. Investors can register\u00a0here. About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT\u00ae and proBEAT\u2122. … Continue reading \"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-12T12:18:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021","datePublished":"2021-07-12T12:18:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/"},"wordCount":291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/","name":"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==","datePublished":"2021-07-12T12:18:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ2OCM0MjkxNzc5IzUwMDA3NzU0Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-13-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511740"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511740\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}